Tim Bettington
Corporate Officer/Principal bei ELANCO ANIMAL HEALTH INCORPORATED
Vermögen: 2 Mio $ am 31.03.2024
Profil
Tim Bettington is currently the Executive Vice President-Corporate Strategy at Elanco Animal Health, Inc. He previously worked as the Executive Vice President & President-US Operations at Zoetis, Inc. and as the Head-Commercial Operations at Boehringer Ingelheim Animal Health USA, Inc. from 2017 to 2019.
He has an undergraduate degree from the University of Western Sydney and a graduate degree from Macquarie Graduate School of Management Pty Ltd.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.04.2024 | 106 387 ( 0,02% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Tim Bettington
| Unternehmen | Position | Beginn |
|---|---|---|
| ELANCO ANIMAL HEALTH INCORPORATED | Corporate Officer/Principal | 20.03.2023 |
Ehemalige bekannte Positionen von Tim Bettington
| Unternehmen | Position | Ende |
|---|---|---|
Boehringer Ingelheim Animal Health USA, Inc.
 Boehringer Ingelheim Animal Health USA, Inc. BiotechnologyHealth Technology Boehringer Ingelheim Animal Health USA, Inc. manufactures biological vaccines for animals. The firm specializes in pharmaceuticals for cattle, equine, pet, and swine. The company was founded by Albrecht Boehringer in 1885 and is headquartered in Duluth, GA. | Corporate Officer/Principal | 01.01.2019 |
| ZOETIS INC. | Corporate Officer/Principal | - |
Ausbildung von Tim Bettington
| University of Western Sydney | Undergraduate Degree |
| Macquarie Graduate School of Management Pty Ltd. | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ZOETIS INC. | Health Technology |
| ELANCO ANIMAL HEALTH INCORPORATED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Boehringer Ingelheim Animal Health USA, Inc.
Boehringer Ingelheim Animal Health USA, Inc. BiotechnologyHealth Technology Boehringer Ingelheim Animal Health USA, Inc. manufactures biological vaccines for animals. The firm specializes in pharmaceuticals for cattle, equine, pet, and swine. The company was founded by Albrecht Boehringer in 1885 and is headquartered in Duluth, GA. | Health Technology |
